Meds Coupons

View Deals

8 Coupons

reuben foster accuser recants; trial decision on may 23 .
  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
    johns hopkins all children's hospital. [jim damaske |times]
  • .

    this procedure is mostly done as an outpatient, meaning the patient is discharged the same day. .

  • .